image
Champions Oncology, Inc. CSBR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.5
0.897 %
$ 61.2 M
Market Cap
-17.31
P/E
CASH FLOW STATEMENT
-6.14 M OPERATING CASH FLOW
-155.17%
Growth Rates
1Year -155.17%
3Years -53.98%
5Years -33.85%
7Years -11.64%
10Years -5.98%
-836 K INVESTING CASH FLOW
70.89%
Growth Rates
1Year 70.89%
3Years 35.87%
5Years -0.05%
7Years -1.26%
10Years -13.58%
-527 K FINANCING CASH FLOW
-4790.91%
Growth Rates
1Year -4790.91%
3Years -12.95%
5Years -7.54%
7Years -1.66%
10Years -38.57%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Champions Oncology, Inc.
image
Net Income -7.28 M
Depreciation & Amortization 1.87 M
Capital Expenditures -836 K
Stock-Based Compensation 1.12 M
Change in Working Capital -3.82 M
Others -320 K
Free Cash Flow -6.97 M

Cash Flow

Millions
Apr-2024 Apr-2023 Apr-2022 Apr-2021 Apr-2020 Apr-2019 Apr-2018 Apr-2017 Apr-2016 Apr-2015 Apr-2014 Apr-2013 Apr-2012 Apr-2011 Apr-2010 Apr-2009 Apr-2008 Apr-2007 Apr-2006 Apr-2005 Apr-2004 Apr-2003 Apr-2002 Apr-2001 Apr-2000 Apr-1999 Apr-1998 Apr-1997 Apr-1996
OPERATING CASH FLOW
Net Income (7.3) (5.3) 0.5 0.3 (2.0) 0.1 (1.5) (6.9) (10.4) (13.1) (7.4) (6.4) (8.7) (3.8) (2.9) (2.2) 35.7 K (0.2) (0.1) (0.2) (0.1) (0.1) (0.1) (0.7) 51.5 K 20 K 0.4 0.3 50 K
Depreciation & Amortization 1.9 2.2 1.6 1.2 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.1 42 K 32 K 4 K 0.2 11 K 0 48.4 K 48.4 K 48.4 K 48.4 K 56.4 K 51.8 K 60 K 60 K 50 K 70 K
Deferred Income Tax 0 1.0 0 49 K 0.6 71 K 44 K 24 K 65 K 100 K 0 10 K 2 K 12 K 22 K 0 0 0 0 0 0 0 0 0.2 0 0 10 K (0.2) 0
Stock Based Compensation 1.1 0.9 0.9 0.6 0.6 0.6 1.0 2.7 2.6 3.2 2.8 2.4 3.3 3.1 0.6 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 2.0 1.0 1.1 0.3 0.4 0.4 0.5 44 K 30 K (0.4) 1.1 65 K (0.4) 36 K 0.2 0.3 0 0 12.4 K 0 0 50 K 50 K 0.3 2.71 K 40 K (0.3) (0.2) (0.2)
Change in Working Capital (3.8) 4.2 2.3 (4.2) 2.5 11 K (1.5) 1.1 1.1 0.4 (0.1) (0.5) 0.4 0.5 1 K 0.6 0.6 80.5 K 37.7 K 0.2 12.8 K (0.2) 16.2 K 0.3 (0.1) 10 K 0.3 0.2 80 K
Cash From Operations (6.1) 4.0 6.5 (1.7) 2.9 1.9 (1.2) (2.8) (6.5) (9.6) (3.4) (4.3) (5.2) 54 K (2.1) (0.9) 0.8 78.5 K 94 K 35.6 K 72.1 K (0.2) 32.7 K 0.1 18.4 K 0.1 0.4 0.1 30 K
INVESTING CASH FLOW
Capital Expenditures (0.8) (2.9) (2.4) (3.3) (2.2) (0.8) (1.2) (0.8) (0.3) (0.1) (0.2) 57 K (0.5) 85 K 84 K (0.1) 0 0 0 0 2.93 K 9.14 K 14.4 K 33.7 K 13.5 K 10 K 20 K 10 K 0
Other Items 0 0 0 0.1 0 0 3 K 0 0 5 K 0 0 0 1 K 1.0 (1.0) 0.4 0 10 K 0 0 0 0 (0.2) 97.3 K 0 0 0 0
Cash From Investing Activities (0.8) (2.9) (2.4) (3.2) (2.2) (0.8) (1.2) (0.8) (0.3) (0.1) (0.2) 57 K (0.5) 84 K 0.9 (1.1) 0.4 0 10 K 0 2.93 K 9.14 K 14.4 K (0.3) (0.1) 10 K 20 K 10 K 0
FINANCING CASH FLOW
Common Stock Repurchased (0.6) 74 K 0 0 0 0 0 0 0 0 0 0 0 (1.0) (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 60 K
Total Debt Repaid (0.1) 0 0 (0.2) 35 K (0.3) 25 K 24 K 24 K 12 K 0 0 0 0 0 0 43.7 K 43.7 K 0 0 4.36 K 1.93 K 10.3 K 8.41 K 5.9 K 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.6 K 0 0 0 0 0 0 0 0
Other Financing Activities 0.3 85 K 0.2 1.4 4.5 1.5 38 K 0 18 K 2.0 21 K 0 97 K 21 K 3 K 57 K 32.8 K 0 0 0 21.6 K 5 K 0 0 0 10 K 20 K 30 K 40 K
Cash From Financing Activities (0.5) 11 K 0.2 1.2 4.4 1.2 13 K 4.3 2 K 13.2 21 K 9.1 97 K 8.1 2.0 57 K 2.5 81.7 K 0 0 1.93 K 3.07 K 44.7 K 8.41 K 5.9 K 10 K 20 K 30 K 40 K
CHANGE IN CASH
Net Change In Cash (7.5) 1.1 4.3 (3.7) 5.1 2.2 (2.4) 0.7 (6.8) 3.5 (3.7) 4.8 (5.7) 7.9 0.8 (2.0) 3.7 3.22 K 84 K 35.6 K 76.9 K (0.3) 2.37 K (0.1) (0.1) 100 K 0.4 80 K 10 K
FREE CASH FLOW
Free Cash Flow (7.0) 1.1 4.1 (5.0) 0.7 1.0 (2.5) (3.6) (6.8) (9.7) (3.7) (4.3) (5.7) (0.1) (2.2) (1.0) 0.8 78.5 K 94 K 35.6 K 75 K (0.3) 47.1 K 0.1 31.8 K 100 K 0.4 100 K 30 K